Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Cash from Financing Activities (2020 - 2026)

PROCEPT BioRobotics has reported Cash from Financing Activities over the past 7 years, most recently at $222000.0 for Q1 2026.

  • Quarterly Cash from Financing Activities fell 82.9% to $222000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $10.1 million through Mar 2026, down 94.34% year-over-year, with the annual reading at $11.2 million for FY2025, 93.79% down from the prior year.
  • Cash from Financing Activities was $222000.0 for Q1 2026 at PROCEPT BioRobotics, down from $4.4 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $170.5 million in Q4 2024 and troughed at -$1.3 million in Q4 2022.
  • The 5-year median for Cash from Financing Activities is $2.4 million (2023), against an average of $21.3 million.
  • Year-over-year, Cash from Financing Activities tumbled 304.66% in 2022 and then skyrocketed 20764.74% in 2023.
  • A 5-year view of Cash from Financing Activities shows it stood at -$1.3 million in 2022, then soared by 317.45% to $2.9 million in 2023, then surged by 5850.03% to $170.5 million in 2024, then tumbled by 97.4% to $4.4 million in 2025, then plummeted by 95.0% to $222000.0 in 2026.
  • Per Business Quant, the three most recent readings for PRCT's Cash from Financing Activities are $222000.0 (Q1 2026), $4.4 million (Q4 2025), and $1.1 million (Q3 2025).